Needle-free injection is an injector which delivers medicine to subcutaneous tissue and intramuscular. The global needle-free injection system market is growing at significant rate, due to mounting occurrence of chronic diseases, and technological improvement. Different types contributed to the needle-free injection system market size. The market has witnessed high demand for liquid-based needle-free injectors due to Benefits of this type have extracted the awareness of various market players.
Insight by Product
On the basis of product the market is subdivided into prefilled needle-free injectors and fillable needle-free injectors. Of all product, prefilled needle-free injectors is expected to grow at fastest rate in the market due to mounting occurrence of chronic diseases such as diabetes, which requires accurate dosage to be administered.
Insight by Technology
The different technologies in the market are vibration-based, spring-based, jet-based and laser-powered. Among the all technologies, the jet-based needle-free injectors are expected to grow at fastest rate and accounted the largest share in the needle-free injection system market, due to its benefits over other technologies.
Insight by Type
On the basis of type market is subdivided into powder-based, liquid-based and projectile/depot-based. Benefits of this type have extracted the awareness of various market players are the factors growing the demand of liquid-based needle-free injectors. Among the all type, the liquid-based needle-free injectors are expected to grow at fastest rate in the needle-free injection system market.
Insight by Usability
On the basis of usability the market is subdivided into reusable needle-fee injectors and disposable needle-free injectors. Among the all usability’s, the reusable needle-fee injectors is expected to grow at fastest rate in the market.
Insight by Site of Delivery
On the basis of site of delivery the market is subdivided into intramuscular injectors, subcutaneous injectors and intradermal injectors. Mounting inclination of patients regarding self-administration of drugs is the factor growing the demand of subcutaneous injectors. Among the all site of delivery, the subcutaneous injectors accounted the largest share in the needle-free injection system market.
Insight by Application
On the basis of application the market is subdivided into oncology, vaccine delivery, pain management, insulin delivery and others. Mounting occurrence of chronic diseases, budding inclination for self-medication and technological improvements are the factors growing the demand of vaccine delivery application. Among the all applications, the vaccine delivery is expected to grow at fastest rate in the needle-free injection system market.
Insight by End User
The different end users of the market are pharmaceutical and biotechnological companies, hospitals and clinics, research laboratories, home care settings and others. Improvement in the drug delivery technology or medication and expanding geriatric population are the factors growing the demand of needle-free injection in hospitals and clinics. Among the all end users, the hospitals and clinics are expected to groe at fastest rate in the needle-free injection system market.
The mounting occurrence of chronic diseases, upsurge in demand for self-injection devices, expanding geriatric population, and mounting occurrence of communicable diseases owing to needlestick injuries are the primary growth drivers for needle-free injection system market.
Mounting need for biosimilars and vaccination and benefits of drug delivery technology are also driving the growth of the market. According to the World Health Organization (WHO), globally approximately 16 billion injections are administered every year in developing and transitional countries.
The higher price of development and alternative modes of drug delivery are the major challenges for the growth of needle-free injection system market.
Globally, the manufacturing companies trying to enter the needle-free injection system market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest needle-free injection system market as in the region the prevalence of chronic disease is increasing. Mounting need for self-administration, and benefits by needle-free injection systems are also up surging growth of the North American needle-free injection system market. For instance, according to Centers for Disease Control and Prevention in 2012, approximately 117 million people in the U.S. had one or the more chronic conditions.
Europe is observed to witness fastest growth in the market, due to mounting healthcare expenditure and escalating need for biologics. In addition, mounting occurrence of chronic diseases, promising reimbursement plans, technological developments, and regulatory consents of novel injection system are also creating a positive impact on the needle-free injection system market growth in the region.
Key players in the needle-free injection system market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In February 2018, Antares Pharma, Inc. received FDA approval for Makena subcutaneous auto injector, to reduce the risk of preterm birth in women. Antares Pharma, Inc., European Pharma Group, National Medical Products, Inc., Endo International PLC, Penject Corporation, Injex Pharma AG, Pharmajet, Valeritas, Inc., Medical International Technology, Inc. (MIT), National Medical Products, Inc. and Crossject are the key players offering needle-free injection system.